del prato diabetes obese metab 2015 17 581-590 - Diabetes Obesity and Metabolism Longterm glycaemic diabetes nellitus etiologu dan patofisiologi response and tolerability of dapagliflozin versus a sulphonylurea as addon therapy to metformin in patients with type 2 diabetes 4year data Del Prato S Nauck M DuranGarcia S Maffei L Rohwedder K Theuerkauf A et al Longterm glycaemic response and tolerability of dapagliflozin versus a sulphonylurea as addon therapy to metformin in patients with type 2 diabetes 4year data Diabetes Obes Metab 2015176581590 doi 101111dom12459 Google Scholar 40 Durability of glycaemic efficacy over 2 years with dapagliflozin versus Emerging Role of SGLT2 Inhibitors for the Treatment of Obesity Longterm glycaemic response and tolerability of dapagliflozin versus a Longterm glycaemic response and tolerability of dapagliflozin versus a sulphonylurea as addon therapy to metformin in patients with type 2 diabetes 4year data Del Prato S Nauck M DuránGarcia S Maffei L Rohwedder K Theuerkauf A Parikh S Diabetes Obes Metab 176581590 06 Apr 2015 Longterm glycaemic response and tolerability of dapagliflozin versus a sulphonylurea as addon therapy to metformin in patients with type 2 diabetes 4year data Del Prato S Nauck M DuránGarcia S Maffei L Rohwedder K Theuerkauf A Parikh S Diabetes Obes Metab 176581590 06 Apr 2015 Del Prato S 0000000253880270 Diabetes Obesity Metabolism 06 Diabetes Obes Metab 171110751084 04 Sep 2015 Cited by 40 articles PMID 26212528 Dapagliflozin a review of its use in type 2 diabetes mellitus Plosker GL Drugs 72 Dapagliflozin versus glipizide as addon therapy in patients with type Longterm glycaemic response and tolerability of dapagliflozin versus a Longterm glycaemic response and tolerability of Europe PMC diabetes mellitus tanda dan gejala Corresponding Author S Del Prato Department of Clinical and Experimental Medicine University of Pisa Pisa Italy Correspondence to Stefano Del Prato MD PhD Section of Diabetes Department of Clinical and Experimental Medicine Ospedale Cisanello Via Paradisa 2 56124 Pisa Italy Email email protected Search for more papers by this author Efficacy and safety of dapagliflozin a sodium glucose cotransporter 2 Del Prato S Nauck M DuranGarcia S Maffei L Rohwedder K Theuerkauf A et al Longterm glycaemic response and tolerability of dapagliflozin versus a sulphonylurea as addon therapy to metformin in patients with type 2 diabetes 4year data Diabetes Obes Metab 201517581590 doi 101111dom12459 Google Scholar 57 Matthaei S Del Prato S Nauck M DuránGarcia S et al Longterm glycaemic response and tolerability of dapagliflozin versus a sulphonylurea as addon therapy to metformin in patients with type 2 diabetes 4year data Diabetes Obes Metab 2015 17 6581590 Google Scholar Del Prato S Nauck M DuránGarcia S Maffei L Rohwedder K Theuerkauf A Parikh S Longterm glycaemic response and tolerability of dapagliflozin versus a sulphonylurea as addon therapy to metformin in patients with type 2 diabetes 4year data Diabetes Obes Metab 201517581590 doi 101111dom12459 Diabetes Obes Metab 2015 Jun176581590 doi 101111dom12459 S Del Prato 1 M Nauck 2 S DuránGarcia 3 L Maffei 4 K Rohwedder 5 A Theuerkauf 6 S Parikh 7 Affiliations 1 Department of Clinical and Experimental Medicine University of Pisa Pisa Italy 2 Diabetes Longterm effects of dapagliflozin plus saxagliptin versus glimepiride Sodium Glucose Cotransporter 2 Inhibitors in makanan buat diabetes the Treatment of Diabetes
contoh menu diabetes seminggu
obat demam untuk penderita diabetes
